Prostatitis
Conditions
Interventions
Intervention group:Drug Infusion + Embolization Therapy
Sponsors
Qilu Second Hospital of Shandong University
Eligibility
Sex/Gender
Male
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Male patients aged >=40years. 2. Meets NIH diagnostic criteria for Type III prostatitis (CP/CPPS) with a symptom duration > 6 months. 3. Inadequate symptom improvement (defined as = 15. 5. Provides informed consent and voluntarily signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Suspected prostate cancer (abnormal PSA and not confirmed as benign by needle biopsy). 2. Acute prostatitis, urinary tract infection. 3. Severe neurogenic bladder, bladder outlet obstruction, or urinary retention. 4. Severe cardiac, hepatic, or renal insufficiency, and coagulation dysfunction. 5. Allergy to contrast agents or NSAIDs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serious Adverse Event (SAE);Clinical success rate at 6 months post-operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the NIH-CPSI total score and subscale scores for pain, urination, and quality of life;Changes in the numerical rating scale (NRS) for pain at various time points after surgery; | — |
Countries
China
Contacts
Public ContactWujie Wang
Second Qilu Hospital of Shandong University
Outcome results
None listed